CLINICAL PREVENTIVE MEDICINE

RABIES

Rabies presents a health threat to Navy and Marine Corps personnel both in the United States and overseas. Timely post-exposure prophylaxis for persons exposed to potentially infected animals is effective in preventing clinical human rabies.

BUMEDINST 6220.13B provides policy for the prevention of rabies among Department of the Navy (DON) personnel and other Military Health System beneficiaries. Navy Environmental and Preventive Medicine Units (NEPMUs) serve as an authoritative source of rabies prevention expertise within DON.

Policy and Guidance

• BUMEDINST 6220.13B: Rabies Prevention and Control
• Assistant Secretary of Defense for Health Affairs ASD(HA) Memo: Human Rabies Prevention During and After Deployment

Forms

• DD FORM 2341 Report of Animal Bite - Potential Rabies Exposure

Web Resources

• Centers for Disease Control and Prevention: Rabies

• CDC Mpox Page
• WHO Mpox Page
• IHD Mpox Vaccine Resource Center
• DHA Mpox Guidance Update_5Sept2024

Clinical guidance, including recognition, management and clinical isolation guidance are generally covered by CDC: CDC Clinical Overview

Clinical management for Fleet medical personnel can be found in the NMCFHPC Fleet Mpox Medical Guidance

Clinical guidance for MTFs can be found in the DHA Mpox Guidance Update_5Sept2024

Currently, neither mpox testing nor treatment are readily available in a forward deployed operational setting. Units should identify suspected cases, isolate them, and move them for care at an MTF when operationally feasible.